CELCUITY INC. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
CELCUITY INC. (CELC) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of -$37.18 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-03-26
- CELCUITY INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was -$37.18M.
- CELCUITY INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was -$23.47M.
- CELCUITY INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2023 was -$13.39M.
- CELCUITY INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2022 was -$8.48M.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month |
|---|---|
| 2025-12-31 | -$37.18M 10-K · filed 2026-03-26 |
| 2024-12-31 | -$23.47M 10-K · filed 2026-03-26 |
| 2023-12-31 | -$13.39M 10-K · filed 2025-03-31 |
| 2022-12-31 | -$8.48M 10-K · filed 2024-03-27 |
| 2021-12-31 | -$6.22M 10-K · filed 2023-03-23 |
| 2020-12-31 | -$1.99M 10-K · filed 2022-03-23 |
| 2019-12-31 | -$1.54M 10-K · filed 2021-02-16 |
| 2018-12-31 | -$1.57M 10-K · filed 2020-03-13 |
| 2017-12-31 | -$682.00K 10-K · filed 2019-03-01 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |